Azitra (AZTR) Intangibles (2022 - 2026)
Azitra's (AZTR) quarterly Intangibles came in at $334522.0 in Q1 2026, up 37.02% YoY from $244140.0 in Q1 2025, and up 5.64% on a QoQ basis from $316673.0 in Q4 2025.
Azitra (AZTR) Intangibles (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Intangibles data on file, last reported at $334522.0 in Q1 2026.
- Quarterly Intangibles rose 37.02% year-over-year to $334522.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $334522.0 (up 37.02% YoY) and the FY2025 annual result came in at $316673.0, up 28.51% from the prior year.
- Intangibles rose to $334522.0 in Q1 2026, from $316673.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $334522.0 in Q1 2026 to a low of $210881.0 in Q4 2023.
- A 5-year average of $252560.3 and a median of $246420.0 in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles dropped 8.26% — and 2026, when it jumped 37.02%.
- Tracing AZTR's Intangibles over 5 years: stood at $219567.0 in 2022, then dropped by 3.96% to $210881.0 in 2023, then rose by 16.85% to $246420.0 in 2024, then grew by 28.51% to $316673.0 in 2025, then climbed by 5.64% to $334522.0 in 2026.
- The last three Intangibles figures came in at $334522.0 (Q1 2026), $316673.0 (Q4 2025), and $270992.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - | 330,039.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 330,039.00 |
| Mar 31, 2026 | 334,522.00 |
| Dec 31, 2025 | 316,673.00 |
| Sep 30, 2025 | 270,992.00 |
| Jun 30, 2025 | 258,665.00 |
| Mar 31, 2025 | 244,140.00 |
| Dec 31, 2024 | 246,420.00 |
| Sep 30, 2024 | 248,739.00 |
| Jun 30, 2024 | 221,630.00 |
| Mar 31, 2024 | 215,099.00 |
| Dec 31, 2023 | 210,881.00 |
| Sep 30, 2023 | 254,376.00 |
| Jun 30, 2023 | 241,580.00 |
| Dec 31, 2022 | 219,567.00 |